Intellia Therapeutics, Inc. (NTLA)
13.42
-0.16
(-1.14%)
USD |
NASDAQ |
Feb 25, 16:00
13.42
0.00 (0.00%)
After-Hours: 16:06
Intellia Therapeutics Research and Development Expense (Quarterly) : 92.33M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 109.77M |
| Personalis, Inc. | 12.17M |
| Regeneron Pharmaceuticals, Inc. | 1.481B |
| Pacific Biosciences of California, Inc. | 22.88M |
| Twist Bioscience Corp. | 17.13M |